Literature DB >> 16611542

[Mycoplasmas: what is the role in human infections?].

Dulce Domingues1, Filipa Nogueira, Luís Tavira, Filomena Exposto.   

Abstract

Mycoplasmas, the common denomination of the Mycoplasma and Ureaplasma genera, represent a unique and complex group of microorganisms that has been ignored by the majority of diagnostic laboratories, not only because of its fastidious growth, absence of commercial media and of procedures for a rapid diagnosis, but most of all due to a clinical perception established for many years that these microorganisms are of minor importance. Recently, this situation has changed, because there s a better understanding of mycoplasmas clinical importance, they have been recently associated with Human Immunodeficiency Virus (HIV), complications in pregnant women and their neonates and with rheumatological disorders, resulting in a need to cure infected persons. The development of laboratory techniques that allows their culture and identification has contributed for a clarification of the role of these microorganisms as etiological agents or as co-factor of specific diseases. This article wishes to be, not only a revision of the main characteristics of the human mycoplasmas, but also to contribute for a better understanding of the diseases to which these fascinating microorganisms are associated and of the available diagnostic methods by the health professionals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16611542

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  2 in total

1.  Experimental infection of BHK21 and Vero cell lines with different Mycoplasma spp.

Authors:  Cristiane Netto; Vanete Thomaz Soccol; Lya Madureira Sepulveda; Jorge Timenetsky
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

Review 2.  Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.

Authors:  Surinder Kumar
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.